Iron, oxygen and placental development in the etiology of preeclampsia. Effects of high altitude in Ecuador;Hierro, oxígeno y desarrollo placentario en la génesis de la preeclampsia. Efectos de la altura en Ecuador

Revista Medica de Chile

Volumn 134, Issue 4, 2006, Pages 491-498

  Escudero, Carlos ^a   Calle, Andrés ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

Author keywords

Anemia, iron deficiency; Placenta; Pre eclampsia

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; IRON; OXYGEN;

ALTITUDE; ANOXIA; ECUADOR; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; METABOLISM; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREECLAMPSIA; PREGNANCY; REPRODUCTION; REVIEW;

ALTITUDE; ANEMIA, IRON-DEFICIENCY; ANOXIA; ECUADOR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IRON; OXYGEN; OXYGEN INHALATION THERAPY; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTERS;

EID: 33744481252     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. National High Blood Pressure Education Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163: 1689-712.
2. TERÁN E, ESCUDERO C, CALLE A. C reactive protein during normal pregnancy and preeclampsia. Int J Gynaecol Obstet 2005; 89: 299-300.
3. ZUPAN J. Perinatal mortality in developing countries. N Engl J Med 2005; 352: 2047-8.
4. REDMAN CW, SARGENT IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-4.
5. MILNE F, REDMAN C, WALKER J, BAKER P, BRADLEY J, COOPER C ET AL. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005; 330: 576-80.
6. SIBAI B, DEKKER G, KUPFERMINC M. Pre-eclampsia. Lancet 2005; 365: 785-99.
7. GOLDMAN-WOHL D, YAGEL S. Regulation of trophoblasto invasion: from normal implantation to preeclampsia. Mol Cell Endocrinol 2002; 187: 233-8.
8. REDMAN C. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12: 301-8.
9. GENBACEV O, ZHOU Y, LUDLOW J, FISHER S. Regulation of human placental development by oxygen tension. Science 1997; 277: 1669-72.
10. DE MARCO C, CANIGGIA I. Mechanisms of oxygen sensing in human trophoblast cells. Placenta 2002; 23: S58-S68.
11. SEMENZA GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 2004; 19: 176-82.
12. BRUNELLE JK, BELL EL, QUESADA NM, VERCAUTEREN K, TIRANTI V, ZEVIANI M ET AL. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1: 409-14.
13. SEMENZA GL. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 2004; 96: 1173-7.
14. LYALL F. Priming and remodelling of human placental bed spiral arteries during pregnancy - a review. Placenta 2005; 26: S31-6.
15. JAFFE R, WARSON S. Transvaginal color Doppler imaging in the assessment of uteroplacental blood flow in the normal first trimester pregnancy. Am J Obstet Gynecol 1991; 164: 781-5.
16. JAUNIAUX E, WATSON A, HEMPSTOCK J, BAO Y, SKEPPER J, BURTON G. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000; 157: 2111-22.
17. GENBACEV O, JOSLIN R, DAMSKY C, POLLIOTI B, FICHER S. Hypoxia alters early gestation human cytotrophoblast differentiation/invasión in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996; 97: 540-50.
18. CANIGGIA I, MOSTACHFI H, WINTER J, GASSMANN M, LYE S, KULISZEWSI M ET AL. Hypoxia-inducible factor -1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3. J Clin Invest 2000; 105: 577-87.
19. SAFRAN M, KAELIN WG JR. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest 2003; 111: 779-83.
20. JAAKKOLA P, MOLE DR, TIAN YM, WILSON MI, GIELBERT J, GASKELL SJ ET AL. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-72.
21. LANDO D, PEET DJ, WHELAN DA, GORMAN JJ, WHITELAW ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295: 858-61.
22. EMERLING BM, PLATANIAS LC, BLACK E, NEBREDA AR, DAVIS RJ, CHANDEL NS. Mitochondrial Reactive Oxygen Species Activation of p38 Mitogen-Activated Protein Kinase Is Required for Hypoxia Signaling. Mol Cell Biol 2005; 25: 4853-62.
23. RAJAKUMAR A, BRANDON HM, DAFTARY A, NESS R, CONRAD KP. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004; 25: 763-9.
24. RAJAKUMAR A, DOTY K, DAFTARY A, MARKOVIC N, CONRAD KP. Expression of von Hippel Lindau (pVHL) Protein in Placentae from Normal Pregnant Women and Women with Preeclampsia. Placenta 2006; 27: 411-21.
25. WHEELER T, SOLLERO C, ALDERMAN S, LANDEN J, ANTHONY F, OSMOND C. Relation between maternal haemoglobin and placental hormone concentration in early pregnancy. Lancet 1994; 343: 511-13.
26. PERRY I, BEEVERS B, WHINCUP P, BAREFORD D. Predictors of ratio of placental weight to fetal weight in multiethnic community. BMJ 1995; 310: 436-39.
27. KADYROV M, SCHMITZ C, BLACK S, KAUFMANN P, HUPPERTZ B. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 2003; 24: 540-8.
28. FREEMAN M, CRAPO J. Hypoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256: 10986-92.
29. WATSON AL, SKEPPER JN, JAUNIAUX E, BURTON GJ. Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab 1998; 83: 1697-705.
30. DUESTERBERG CK, COOPER WJ, WAITE TD. Fenton-mediated oxidation in the presence and absence of oxygen. Environ Sci Technol 2005; 39: 5052-8.
31. DENDORFER A, HEIDBREDER M, HELLWIG-BURGEL T, JOHREN O, QADRI F, DOMINIAK P. Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med 2005; 38: 117-24.
32. RED-HORSE K, ZHOU Y, GENBACEV O, PRAKOBPHOL A, FOULK R, MCMASTER M ET AL. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004; 114: 744-54.
33. VANDERLELIE J, VENARDOS K, CLIFTON VL, GUDE NM, CLARKE FM, PERKINS AV. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005; 26: 53-8.
34. KEYES LE, ARMAZA JF, NIERMEYER S, VARGAS E, YOUNG DA, MOORE LG. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res 2003; 54: 20-5.
35. PALMER SK, MOORE LG, YOUNG D, CREGGER B, BERMAN JC, ZAMUDIO S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol 1999; 180: 1161-8.
36. SOLEYMANLOU N, JURISICA I, NEVO O, IETTA F, ZHANG X, ZAMUDIO S ET AL. Molecular Evidence of Placental Hypoxia in Preeclampsia. J Clin Endocrinol Metab 2005; 90: 4299-308.
37. LÓPEZ-JARAMILLO P, GARCÍA RG, LÓPEZ M. Preventing pregnancy-induced hypertension: are there regional differences for this global problem? J Hypertens 2005; 23: 1121-9.
38. VUORINEN K, REMES A, SORMUNE R, TAPANAINEN J, HASSEINEN I. Placental mitochondrial DNA and respiratory chain enzymes in the etiology of preeclampsia. Obstet Gynecol 1998; 91: 950-5.
39. FURUI T, KARAUCHI O, TANAKA M, MIZUTANI S, OZAWA T, TOMODA Y. Decrese in cytochrome c oxidase and cytochrome oxidase subunit I messenger RNA levels in preeclamptic pregnancies. Obstet Gynecol 1994; 84: 283-88.
40. ASKEW EW. Work at high altitude and oxidative stress: antioxidant nutrients. Toxicology 2002; 180: 107-19.
41. LÓPEZ-JARAMILLO P, TERÁN E, RINGQVIST A, MOYA W, RIVERA J, BERRAZUETA JR. Oxidised low-density lipoproteins and nitric oxide during normal pregnancy and preeclampsia. In: Moncada S, Toda N, Maeda H, Higgs EA, eds. Biology of Nitric Oxide Part 6. Portland Press: London. 1998. pp. 322.
42. TERÁN E, RACINES M, VIVERO S, ESCUDERO C, MOLINA G, CALLE A. Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels. Free Rad Biolo Med 2003; 35: 1453-56.
43. TERÁN E, ESCUDERO C, VIVERO S, MOYA W, CALLE A. Alter release of nitric oxide from nitrosoprotein. Am J Obst Gynecol. 2006; 92: 260-1.
44. POSTON L, RAIJMAKERS M, KELLY F. Vitamin E in preeclampsia. Ann N Y Acad Sci 2004; 1031: 242-8.
45. KHARFI A, GIGUERE Y, DE GRANDPRE P, MOUTQUIN JM, FOREST JC. Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies. Clin Biochem 2005; 38: 717-21.
46. TERÁN E, ESCUDERO C, VIVERO S, CALLE A, MOLINA G. Plasma nitric oxide levels during normal pregnancy and preeclampsia. A follow study. Hypertension. 2006; 47: 17.
47. TERÁN E, ESCUDERO C, VIVERO S, ENRÍQUEZ A, CALLE A. Intraplatelet cyclic guanosine-3′,5′-monophosphate levels during pregnancy and preeclampsia. Hypertens Pregnancy 2004; 23: 303-8.
48. TERÁN E, ESCUDERO C, MOYA W, FLORES M, VALLANCE P, LÓPEZ-JARAMILLO P. Elevated C-reactive protein and pro-inflammatory cytoquines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001; 75: 243-9.
49. TERÁN E, ESCUDERO C, CALLE A. Seroprevalence of antibodies of Chlamydia Pneumoniae, Helicobacter Pylori and Streptolysine O as a risk factor to develop preeclampsia. Obstetric and Gynecology 2003; 102: 198-9.
50. CHAPPELL L, SEED P, BRILEY A, KELLY F, LEE R, HUNT B ET AL. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999; 354: 810-6.
51. YEPEZ R, CALLE A, GALAN P, ESTÉVEZ E, DÁVILA M, ESTRELLAR R ET AL. Iron status in Ecuadorian pregnant women living at 2,800 m altitude: relationship with infant iron status. Int J Vitam Nutr Res 1987; 57: 327-32.
52. YEPEZ R, ESTEVEZ E, GALAN P, CHAULIAC M, DÁVILA M, CALLE A ET AL. High altitude anemia: validity of definition criteria. Sante: 1994; 4: 9-13.
53. CALLE A. Vitaminas. En: Nutrición durante el Embarazo, Primera Edición. Calle A. Autor-Editor. Publicaciones Médicas, 2000. Quito, Ecuador, 2000: 51-101.
54. SCHOLL TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005; 81: 1218S-22S.
55. Instituto Nacional Ecuatoriano de Estadísticas y Censos. INEC, 1997.
56. WEIGEL M, NARVÁEZ M, FÉLIX C, LÓPEZ A, LÓPEZ-JARAMILLO P. Prenatal diet, nutrient intake and pregnancy outcome in urban Ecuadorian primiparas. Arch Latinoam Nutr 1991; 41: 21.
57. VILLAR J, SAY L, SHENNAN A, LINDHERIMER M, DULEY L, CONDE-AGUDELO A ET AL. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynecol Obstet 2004; 85: S28-S41.
58. VILLAR J, CONDE-AGUDELO A, LINDHEIMER M. World health organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104: 1367-91.